Financing ·
FDA approves Obagi saypha ChIQ Injectable Hyaluronic Acid Gel
WALDWaldencast plc
Waldencast plc announced two significant developments. On June 11, 2026, subsidiaries Milk Makeup LLC and Obagi Cosmeceuticals LLC entered into a Second Amendment to their Credit Agreement, which postpones the requirement to issue warrants for Term Tranche B Loans from July 1, 2026, to November 17, 2026. Additionally, on June 15, 2026, the company announced that Obagi Medical received FDA approval for Obagi® saypha® ChIQ™ Injectable Hyaluronic Acid Gel. Waldencast plc is a beauty and skincare company that operates through various brands including Obagi Medical and Milk Makeup.